ELIZABETH RHAMY: Open Payments
NPI 1831398171 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,748 in 106 payments from 27 companies in 2025. Trend: 2023 $1,141 · 2024 $1,189 · 2025 $1,748
Food & beverage: $1,748
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $272 |
| PFIZER INC. | 19 | $246 |
| AstraZeneca Pharmaceuticals LP | 4 | $198 |
| Phathom Pharmaceuticals, Inc. | 3 | $149 |
| Amgen Inc. | 15 | $142 |
| Radius Health, Inc. | 3 | $85 |
| GlaxoSmithKline, LLC. | 4 | $66 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Abbott Laboratories | 3 | $53 |
| Lilly USA, LLC | 3 | $51 |
Products named: AIRSUPRA, UBRELVY, VOQUEZNA, PREVNAR 20, OTEZLA, Tymlos, NURTEC ODT, TRELEGY ELLIPTA.
Industry payments across VA — which companies pay providers there.
